Google announced it is licensing its AI model focused on detecting diabetic retinopathy to partners in Thailand and India, two countries the tech giant says have a shortage of eye specialists.
Google Research teams partnered with foundational research partners Aravind Eye Hospital in India and Rajavithi Hospital in Thailand nearly a decade ago to research whether AI could be used to help reduce...
Israeli startup AEYE Health announced last week it had received FDA 510(k) clearance for its AI-based screening tool for diabetic retinopathy.
The AEYE-DS system, which received the agency's green light earlier this month, uses images from each eye to detect signs of more-than-mild diabetic retinopathy, a complication from diabetes that can lead to blindness or other serious vision problems.
It'...
The Industrial Technology Research Institute, a non-profit R&D organisation in Taiwan, has unveiled its AI-assisted system for detecting diabetic eye diseases.
WHAT IT'S ABOUT
Point-of-care AI-DR can instantly diagnose diabetic retinopathy and diabetic eye oedema in five to 10 seconds. It can locate from fundus images four main lesions – microaneurysms, haemorrhages, soft exudates, and hard...
New research out of Thailand found that a deep learning algorithm was able to diabetic retinopathy in patients with diabetes on par with community specialists, according to a study published in The Lancet.
Researchers discovered that the deep-learning system was able to detect vision-threatening diabetic retinopathy with an accuracy of 94.7%, sensitivity of 91.4% and specificity of 95.4%. This...
Johnson & Johnson Vision, the eye health unit of Johnson & Johnson Medical Devices Companies, has revealed its three-year roadmap to develop an integrated eye health ecosystem in Singapore that focuses on data and digitalisation initiatives.
WHAT IT'S ABOUT
The company said in a media release that it will build a consumer-centric, experiential eye health ecosystem that seamlessly...
Implementation of either an automated or semi-automated deep learning system for diabetic retinopathy screening could lead to cost savings at the health-system level, according to an economic analysis modeling study recently published in The Lancet Digital Health.
Backed by Singapore's Ministry of Health, the investigation looked at data from a national diabetic retinopathy screening program...
Virtual until proven fraudulent. A New York anesthesiologist has been indicted for her role in a scheme to submit fraudulent telemedicine claims to Medicare, Medicare Part D plans as we. According to the indictment, Dr. Anna Steiner and other providers purported to practice telemedicine in exchange for kickbacks starting in 2015. This resulted in more than $7 million in Medicare claims on behalf...
Wearables, services perform well for Apple. While iPhone sales and overall Q2 revenue were down in 2019, the company was fairly optimistic on its most recent earnings report due to substantial growth among its wearables, iPads and services businesses.
In terms of healthcare, CEO Tim Cook noted during the investors’ call that the past quarter included the rollout of the Apple Watch Series 4’s ECG...
Google has been busy recently. Just in the past week it has closed down its Google Fit website, launched a new drug disposal tool and announced the first clinical use of Verily’s machine learning tool for diabetic related diseases.
Below is a look at three of the company’s digital health announcements in the last week.
Addressing the opioid crisis
It started last Wednesday when Google...
Pivotal trial data that led to April’s de novo clearance of the first AI-based diagnostic system to not require clinician interpretation is now available to the public. Published today in npj Digital Medicine, this 900-patient investigation showed that the IDx-Dr system for autonomous detection of diabetic retinopathy “robustly exceeded the pre-specified primary endpoint goals” and is able to...
